A combination of RBD and NTD neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants D Haslwanter, ME Dieterle, AZ Wec, CM O’Brien, M Sakharkar, C Florez, ... bioRxiv, 2021 | 5 | 2021 |
A combination of receptor-binding domain and N-terminal domain neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants D Haslwanter, ME Dieterle, AZ Wec, CM O’brien, M Sakharkar, C Florez, ... Mbio 12 (5), e02473-21, 2021 | 39 | 2021 |
A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition ME Dieterle, D Haslwanter, RH Bortz III, AS Wirchnianski, G Lasso, ... Cell host & microbe 28 (3), 486-496. e6, 2020 | 206 | 2020 |
Broad neutralization of SARS-related viruses by human monoclonal antibodies AZ Wec, D Wrapp, AS Herbert, DP Maurer, D Haslwanter, M Sakharkar, ... Science 369 (6504), 731-736, 2020 | 545 | 2020 |
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein AZ Wec, D Wrapp, AS Herbert, D Maurer, D Haslwanter, M Sakharkar, ... BioRxiv, 2020 | 26 | 2020 |
Characterization of prophages containing “evolved” Dit/Tal modules in the genome of Lactobacillus casei BL23 ME Dieterle, J Fina Martin, R Durán, SI Nemirovsky, C Sanchez Rivas, ... Applied microbiology and biotechnology 100 (21), 9201-9215, 2016 | 34 | 2016 |
Characterization of the SARS-CoV-2 S Protein: Biophysical NG Herrera, NC Morano, A Celikgil, GI Georgiev, RJ Malonis, JH Lee, ... Biochemical, Structural, and Antigenic Analysis. bioRxiv 2020 (14.150607), 2020 | 11 | 2020 |
Characterization of the SARS-CoV-2 S protein: biophysical, biochemical, structural, and antigenic analysis NG Herrera, NC Morano, A Celikgil, GI Georgiev, RJ Malonis, JH Lee, ... ACS omega 6 (1), 85-102, 2020 | 85 | 2020 |
Complete Genome Sequences of Lactobacillus Phages J-1 and PL-1 ME Dieterle, D Jacobs-Sera, D Russell, G Hatfull, M Piuri Genome announcements 2 (1), e00998-13, 2014 | 7 | 2014 |
Development, clinical translation, and utility of a COVID-19 antibody test with qualitative and quantitative readouts RH Bortz III, C Florez, E Laudermilch, AS Wirchnianski, G Lasso, ... medRxiv, 2020 | 7 | 2020 |
Evolved distal tail carbohydrate binding modules of Lactobacillus phage J‐1: a novel type of anti‐receptor widespread among lactic acid bacteria phages ME Dieterle, S Spinelli, I Sadovskaya, M Piuri, C Cambillau Molecular microbiology 104 (4), 608-620, 2017 | 39 | 2017 |
EXPOSING THE SECRETS OF TWO WELL KNOWN DAIRY PHAGES: GENOMIC AND STRUCTURAL ANALYSIS OF J-1 AND PL-1 ME Dieterle, C Bowman, C Batthyany, E Lanzarotti, A Turjanski, G Hatfull, ... BIOCELL 38, 72-72, 2014 | | 2014 |
Exposing the secrets of two well-known Lactobacillus casei phages, J-1 and PL-1, by genomic and structural analysis ME Dieterle, C Bowman, C Batthyany, E Lanzarotti, A Turjanski, G Hatfull, ... Applied and Environmental Microbiology 80 (22), 7107-7121, 2014 | 26 | 2014 |
Functional antibodies in COVID-19 convalescent plasma JD Herman, C Wang, C Loos, H Yoon, J Rivera, ME Dieterle, ... Medrxiv, 2021 | 7 | 2021 |
Genetic depletion studies inform receptor usage by virulent hantaviruses in human endothelial cells ME Dieterle, C Solà-Riera, C Ye, SM Goodfellow, E Mittler, E Kasikci, ... Elife 10, e69708, 2021 | 17 | 2021 |
Genome Sequence and Characterization of Lactobacillus casei Phage, vB_LcaM_Lbab1 Isolated from Raw Milk V Gradaschi, F Payaslian, ME Dieterle, L Rondón Salazar, E Urdániz, ... Therapy, Applications, and Research 2 (1), 57-63, 2021 | 3 | 2021 |
Genomic surveillance of SARS-CoV-2 during the first year of the pandemic in the Bronx enabled clinical and epidemiological inference JM Fels, S Khan, R Forster, KA Skalina, S Sirichand, AS Fox, A Bergman, ... Molecular Case Studies 8 (5), a006211, 2022 | 2* | 2022 |
Hantavirus entry: Perspectives and recent advances E Mittler, ME Dieterle, LM Kleinfelter, MM Slough, K Chandran, RK Jangra Advances in virus research 104, 185-224, 2019 | 93 | 2019 |
Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals NA Muena, T García-Salum, C Pardo-Roa, MJ Avendaño, EF Serrano, ... EBioMedicine 78, 103972, 2022 | 33 | 2022 |
Isolation and Characterization of vB_MsmS_Celfi: A New Mycobacterium tuberculosis Bacteriophage F Payaslian, V Gradaschi, L Rondón Salazar, ME Dieterle, E Urdániz, ... Therapy, Applications, and Research 2 (1), 43-49, 2021 | 1 | 2021 |